Bromide

Bromide

SCHEMBL5143840

CCCCCC[n+]1cn(C)c2ccccc21.[Br-]

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 8/20 0.40
NPSR1 Q6W5P4 4/20 0.49
KDM4E B2RXH2 4/20 0.49
NPC1 O15118 4/20 0.49
HTT P42858 4/20 0.49
RAB9A P51151 4/20 0.49
SMN1; SMN2 Q16637 4/20 0.49
RAD52 P43351 3/20 0.49
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
LMNA P02545 2/20 0.49
MAPK1 P28482 2/20 0.49
RGS12 O14924 1/20 0.49
USP2 O75604 1/20 0.49
HSP90AA1 P07900 1/20 0.49
THRB P10828 1/20 0.49
MCL1 Q07820 1/20 0.49
ALDH1A1 P00352 4/20 0.43
GAA P10253 3/20 0.43
CYP1A2 P05177 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL17317392 1.00 NPSR1 (0.49) NPSR1KDM4ENPC1HTTRAB9A
SCHEMBL21049542 0.98 KDM4E (0.50) NPSR1KDM4ENPC1HTTRAB9A
SCHEMBL17317384 0.98 KDM4E (0.50) NPSR1KDM4ENPC1HTTRAB9A
SCHEMBL21049556 0.98 KDM4E (0.50) NPSR1KDM4ENPC1HTTRAB9A
SCHEMBL21049615 0.98 KDM4E (0.50) NPSR1KDM4ENPC1HTTRAB9A
Bromide SCHEMBL5143677 0.94 PTPN1 (0.42) NPSR1KDM4ENPC1HTTRAB9A
Bromide SCHEMBL29479429 0.94 BCHE (0.44) NPC1RAB9ASMN1; SMN2BCHEACHE
SCHEMBL3698833 0.92 PTPN1 (0.43) NPSR1KDM4ENPC1HTTRAB9A
Fluoride Ion SCHEMBL9329663 0.90 PTPN1 (0.42) NPSR1KDM4ENPC1HTTRAB9A
SCHEMBL3693226 0.90 BCHE (0.41) BCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7273953-B2 Process for producing arylamine FUJIFILM FINECHEMICALS CO., LTD. (JP) 2007-09-25 US disclosed
US-20060069287-A1 Process for producing arylamine FUJIFILM FINECHEMICALS CO., LTD. (JP) 2006-03-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060069287-A1 Process for producing arylamine TYR, AADAC, AOC2 ACHE 1678/4885NPSR1 4136/4885KDM4E 1302/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.